ÂÜÀòÂÒÂ×

Dan Brownell is the Director of Research and Development at AOBiome Therapeutics, responsible for leading preclinical and R&D programs since joining in 2018. Dan brings 20 years of scientific experience, with a focus on the use of microorganisms to achieve positive outcomes. At AOBiome, Dan leads a high-performing team of scientists responsible for better understanding the mechanisms of action of AOB and their use as a treatment for the disease.

Prior to AOBiome, Dan held diverse roles within the biotech community, including in the fields of rapid diagnostics, synthetic biology, and biofuels.